Change in the clinical development program for laquinimod

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Change in the clinical development program for laquinimod

Postby MSUK » Wed Feb 19, 2014 8:26 am

Active Biotech today announces that its partner Teva Pharmaceuticals, has decided not to proceed to the randomization stage of the planned Libretto trial for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS), as the current design is no longer aligned with the regulatory strategy. This decision has no impact on other ongoing studies, such as CONCERTO, which are proceeding as planned, or on Teva Pharmaceuticals' plans to initiate clinical studies in Primary Progressive Multiple Sclerosis (PPMS)......Read More - http://www.ms-uk.org/laquinimod
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2175
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service